Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic acid-reflux, cancer and other drugs from a new pharmacy backed by investor Mark Cuban, according to Harvard Medical School researchers.
Mr. Cuban, the billionaire internet entrepreneur and owner of the NBA’s Dallas Mavericks, launched his pharmacy in January with an eye toward disrupting the $365 billion U.S. prescription-drug market by sidestepping health-insurers and selling commonly used generic medicines directly to consumers with a transparent, fixed-rate markup pricing model.
Source: finance.yahoo.com
Related posts:
Crypto Billionaire Rankles Wall Street Titans With Derivatives Plan
5 Signs You Might Run Out of Money in Retirement ( & How to Prevent It)
Subprime Auto Lender American Car Center Closes for Business
Only 6 pure EVs on sale today qualify for the full EV tax credit
How Long Will $250,000 Last Me in Retirement?